EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin‐Homing T Cells of Atopic Dermatitis Patients

Ahmed M I Elfiky iD, Hidde M Smits iD, Marlot van der Wal, Coco Dekkers iD, Celeste M Boesjes iD, Julia Drylewicz iD, Marjolein de Bruin-Weller iD, Femke van Wijk

Clinical & Experimental Allergy · 2026-11 · 56 (11) · 1452-1455

DOI: 10.1111/cea.70397 ↗

At a glance

Journal article in Clinical & Experimental Allergy, published online on 2026-07-15. Written by Ahmed M I Elfiky and 7 co-authors. Institution: Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. 8 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Health~Holland, the Top Sector Life Sciences & Health.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Skin‐homing T‐helper cells show a unique DNA methylome in AD. Dupilumab partially corrects, whereas upadacitinib broadens methylation differences and reinforces AD‐related methylation signatures.

Authors and institutions

  • Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.

ORCID profiles: Ahmed M I Elfiky, Hidde M Smits, Coco Dekkers, Celeste M Boesjes, Julia Drylewicz, Marjolein de Bruin-Weller

Funding

  • Health~Holland, the Top Sector Life Sciences & Health

Cite

APA

Elfiky, A. M. I., Smits, H. M., van der Wal, M., Dekkers, C., Boesjes, C. M., Drylewicz, J., de Bruin-Weller, M., & van Wijk, F. (2026). Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin‐Homing T Cells of Atopic Dermatitis Patients. Clinical & Experimental Allergy, 56(11), 1452-1455. https://doi.org/10.1111/cea.70397

Vancouver

Elfiky AMI, Smits HM, van der Wal M, Dekkers C, Boesjes CM, Drylewicz J, et al. Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin‐Homing T Cells of Atopic Dermatitis Patients. Clinical & Experimental Allergy. 2026;56(11):1452-1455. doi:10.1111/cea.70397

BibTeX
@article{Elfiky2026,
  author = {Elfiky, Ahmed M I and Smits, Hidde M and van der Wal, Marlot and Dekkers, Coco and Boesjes, Celeste M and Drylewicz, Julia and de Bruin-Weller, Marjolein and van Wijk, Femke},
  title = {Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin‐Homing T Cells of Atopic Dermatitis Patients},
  journal = {Clinical & Experimental Allergy},
  year = {2026},
  volume = {56},
  number = {11},
  pages = {1452--1455},
  doi = {10.1111/cea.70397}
}
Start for free →